A Cedars-Sinai Heart Institute patient became the first in the nation to undergo the newly approved non-surgical procedure to fix their leaky and life-threatening heart valve condition.



The Cardiovascular Research Foundation (CRF) and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced the initiation of the Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT II) trial and the PROSPECT ABSORB sub study.


The U.S. Food and Drug Administration (FDA) approved Cardiovascular Systems Inc.’s Diamondback 360 Coronary Orbital Atherectomy System (OAS) for treatment of patients with severely calcified coronary lesions and who are candidates for percutaneous transluminal coronary angioplasty (PTCA) and have previously not been treated.

Corindus Vascular Robotics, a provider of precision medical robotics, announced the launch of its CorPath One Stent Program.

PHS Technologies Group LLC, a division of PACSHealth LLC, announced that it has been awarded a group purchasing agreement with Premier, Inc. for DoseMonitor, its radiation dose tracking system. 

Abbott announced clinically meaningful changes to quality of life, a reduction in rehospitalization for heart failure, and functional improvements for patients treated with the company's first-in-class, catheter-based MitraClip therapy for patients with degenerative mitral regurgitation (MR). Findings were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco and simultaneously published in the Journal of the American College of Cardiology.  


The American College of Radiology (ACR) applauded a joint Senate Finance and House Committee on Ways and Means’ proposal to require ordering physicians to consult appropriateness criteria for advanced imaging services provided to Medicare patients.


Subscribe Now